Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA.
about
Hepatitis VaccinesAntigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.The impact of new technologies on vaccine development.Hepatitis B virus infection. Current concepts of chronicity and immunity.Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replicationFunctional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome.Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture.Recombinant retroviral DNA yielding high expression of hepatitis B surface antigen.Secretion of the hepatitis B virus surface antigen from mouse cells using an extra-chromosomal eucaryotic vector.Hepatitis B virus antigens made in microbial cells immunise against viral infection.Morphogenesis of hepatitis B virus and its subviral envelope particlesLow-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responsesTranscriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism.DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.In vitro propagation of human hepatitis B virus in a rat hepatoma cell line.TGF-β and iron differently alter HBV replication in human hepatocytes through TGF-β/BMP signaling and cellular microRNA expression.Avian and Mammalian hepadnaviruses have distinct transcription factor requirements for viral replication.Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta.Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.A dominant modifier of transgene methylation is mapped by QTL analysis to mouse chromosome 13Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vectorRole of peroxisome proliferator-activated receptor gamma coactivator 1alpha in AKT/PKB-mediated inhibition of hepatitis B virus biosynthesis.Detection of hepatitis B virus X product using an open reading frame Escherichia coli expression vector.Complementarity between epsilon and phi sequences in pregenomic RNA influences hepatitis B virus replication efficiency.Limited effects of bile acids and small heterodimer partner on hepatitis B virus biosynthesis in vivo.Regulation of transcription from the hepatitis B virus large surface antigen promoter by hepatocyte nuclear factor 3.Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes.Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter.Endogenous antiviral microRNAs determine permissiveness for hepatitis B virus replication in cultured human fetal and adult hepatocytes.Secreted hepatitis B surface antigen polypeptides are derived from a transmembrane precursor.Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNAInduction of human beta-interferon synthesis with poly(rI . rC) in mouse cells transfected with cloned cDNA plasmids.Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment.Differential inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by the small heterodimer partner.Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter.Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor.A liver-specific nuclear factor interacts with the promoter region of the large surface protein gene of human hepatitis B virus
P2860
Q26765433-CE7266C7-506F-4471-87BC-B01806553969Q27469889-0AE2CB77-5094-44DC-A832-6D39F48BBBA1Q30411839-91FB423D-4EA7-43F0-B85E-7251BF38D764Q33581104-793AC8B2-9241-4174-BAA1-041659A0B1FEQ33614622-BD90695D-4E23-4C23-AC36-0113C18E2BA8Q33754980-6A6EB31D-1208-43A7-BF97-3CCC622F915AQ33833777-7FF6FDCF-0F32-48C0-8124-0DA785CCB876Q33845008-5A8F11FE-52C0-4A18-9D10-27054E2C9B3CQ33928305-F8CE6414-B0BC-4A89-9DCE-B399AB782248Q33933483-6D2ABDF5-0DF2-44D9-BBD5-51067ECFCE49Q33939409-96A0F967-F428-4071-A7ED-C4406B207843Q34018886-40A0F171-6002-4BC0-A9F2-1C6EE9CAEA62Q34045548-07D1470F-F5FF-4134-BDBC-6EC49386D218Q34106871-3EA04068-D7DF-4722-9429-C64096C44B95Q34209003-C26F2CA8-9CD8-46E0-8B4C-88E0800C1D9CQ34297961-38B1FF2F-C110-442C-AF2E-CE68CA1BA1F2Q34314364-CC86049C-58CB-42D7-9311-2C8C84433536Q34343441-173D17BE-6FCA-43DF-B35D-94B507BF89CEQ34344259-D5A4BA8C-F0AA-45EB-A89B-5E7CD2161A0BQ34596607-E310C4F6-3412-4BE9-92CC-A990C466B319Q35033574-F38FB901-CD8C-4B37-B9ED-7C84695D1E80Q35355405-016F13DC-19BD-466B-B63D-6275C9FEAF43Q35531347-FB94EC71-9AE8-4294-AA4F-FCABBB350067Q35597968-C278724B-4505-4424-BDB4-06A976E78350Q35748415-035A72E9-4576-4888-9F93-7DB3DB923671Q35826094-29FC0D63-9F85-4922-BD61-1CDA48AC5DBEQ35839357-C1A13FA9-5A1D-49D5-8EDF-F6AA313619C3Q35848639-2D7A7DD4-371A-4A96-800A-EA67E981CD42Q35876404-D1F1038A-9B91-425E-94AD-02668BFB916CQ35954830-6A8D4D7C-F955-423B-83C3-5C7ECF5E96A9Q36221120-E3885661-FA04-4D73-8463-8766F2FB68F7Q36278570-7D4B3B63-2F42-4539-A62E-601613EB35D6Q36281860-FEBB04BA-D519-4A83-8C8F-9BCF0ADE1B17Q36286947-3A4F47D1-91AC-4B68-B284-D975C1DE3820Q36304501-F25488DE-53B4-489F-939B-E5F6B4D1666EQ36531845-B460DB24-D79A-4D52-AFAC-DB6ABB7DE523Q36540002-1F095265-7FA8-40EE-A30E-4483EC8CD7A8Q36643638-13481E9A-BD7D-40E1-8CCC-599C5C2F902FQ36686383-647EC899-F2BB-49ED-B773-959ACD48DF41Q36796326-87BBE70F-A42A-4B04-9DD0-D61C5ABE4BF5
P2860
Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Excretion of hepatitis B surfa ...... sformed with cloned viral DNA.
@ast
Excretion of hepatitis B surfa ...... sformed with cloned viral DNA.
@en
type
label
Excretion of hepatitis B surfa ...... sformed with cloned viral DNA.
@ast
Excretion of hepatitis B surfa ...... sformed with cloned viral DNA.
@en
prefLabel
Excretion of hepatitis B surfa ...... sformed with cloned viral DNA.
@ast
Excretion of hepatitis B surfa ...... sformed with cloned viral DNA.
@en
P2093
P2860
P356
P1476
Excretion of hepatitis B surfa ...... nsformed with cloned viral DNA
@en
P2093
P2860
P304
P356
10.1073/PNAS.77.8.4549
P407
P577
1980-08-01T00:00:00Z